Thrombin-activated interleukin-1α drives atherogenesis, but also promotes vascular smooth muscle cell proliferation and collagen production
Cardiovascular Research · 2023
DOI: 10.1093/cvr/cvad091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2023. Verfasst von Laura C Burzynski und 7 weiteren Autor:innen. Beteiligte Einrichtung: Section of CardioRespiratory Medicine, The Heart and Lung Research Institute, The University of Cambridge, Papworth Road, Cambridge Biomedical Campus…. Hauptthemen laut MEDLINE: Atherosclerosis, Plaque, Atherosclerotic, Thrombin. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Department of Health, British Heart Foundation Grants.
Abstract (Originalsprache)
Aims
Atherosclerosis is driven by multiple processes across multiple body systems. For example, the innate immune system drives both atherogenesis and plaque rupture via inflammation, while coronary artery-occluding thrombi formed by the coagulation system cause myocardial infarction and death. However, the interplay between these systems during atherogenesis is understudied. We recently showed that coagulation and immunity are fundamentally linked by the activation of interleukin-1α (IL-1α) by thrombin, and generated a novel knock-in mouse in which thrombin cannot activate endogenous IL-1α [IL-1α thrombin mutant (IL-1αTM)]. Methods and results Here, we show significantly reduced atherosclerotic plaque formation in IL-1αTM/Apoe−/− mice compared with Apoe−/− and reduced T-cell infiltration. However, IL-1αTM/Apoe−/− plaques have reduced vascular smooth muscle cells, collagen, and fibrous caps, indicative of a more unstable phenotype. Interestingly, the reduced atherogenesis seen with thrombin inhibition was absent in IL-1αTM/Apoe−/− mice, suggesting that thrombin inhibitors can affect atherosclerosis via reduced IL-1α activation. Finally, bone marrow chimeras show that thrombin-activated IL-1α is derived from both vessel wall and myeloid cells.
Conclusions
Together, we reveal that the atherogenic effect of ongoing coagulation is, in part, mediated via thrombin cleavage of IL-1α. This not only highlights the importance of interplay between systems during disease and the potential for therapeutically targeting IL-1α and/or thrombin, but also forewarns that IL-1 may have a role in plaque stabilization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of CardioRespiratory Medicine, The Heart and Lung Research Institute, The University of Cambridge, Papworth Road, Cambridge Biomedical Campus, Cambridge CB2 0BB, UK.
ORCID-Profile: Murray C H Clarke
Förderung
- British Heart Foundation
- Department of Health
- British Heart Foundation Grants
- BHF Cambridge Centre for Research Excellence
- Cambridge NIHR Biomedical Research Centre
Zitieren
APA
Burzynski, L. C., Morales-Maldonado, A., Rodgers, A., Kitt, L. A., Humphry, M., Figg, N., Bennett, M. R., & Clarke, M. C. H. (2023). Thrombin-activated interleukin-1α drives atherogenesis, but also promotes vascular smooth muscle cell proliferation and collagen production. Cardiovascular Research. https://doi.org/10.1093/cvr/cvad091
Vancouver
Burzynski LC, Morales-Maldonado A, Rodgers A, Kitt LA, Humphry M, Figg N, et al. Thrombin-activated interleukin-1α drives atherogenesis, but also promotes vascular smooth muscle cell proliferation and collagen production. Cardiovascular Research. 2023. doi:10.1093/cvr/cvad091
BibTeX
@article{Burzynski2023,
author = {Burzynski, Laura C and Morales-Maldonado, Alejandra and Rodgers, Amanda and Kitt, Lauren A and Humphry, Melanie and Figg, Nichola and Bennett, Martin R and Clarke, Murray C H},
title = {Thrombin-activated interleukin-1α drives atherogenesis, but also promotes vascular smooth muscle cell proliferation and collagen production},
journal = {Cardiovascular Research},
year = {2023},
doi = {10.1093/cvr/cvad091}
}
EUVIMED